Skip to Main Content

Paper Details

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.
Transplant Cell Ther
3
2022
Author NameAffiliation
Guy SauvageauUniversite de Montreal
Denis-Claude RoyUniversite de Montreal
  • 1 - 2

Datasets

Release 1.2